Concourse Financial Group Securities’s Monopar Therapeutics MNPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5096 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6035 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6026 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6049 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6049 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5985 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5869 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5738 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5529 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5521 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5338 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5339 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5236 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5253 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5113 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 4952 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 4815 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4684 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4492 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4369 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4360 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4301 |
|